Apr 10, 2017 12:03 pm UTC| Business
LAS VEGAS, April 10, 2017 -- THC Therapeutics (OTC:THCT) is a publicly traded health and healing cannabis company. We are excited to announce that we have accomplished the first step of our stated plans for the growth...
Apr 10, 2017 12:04 pm UTC| Business
LAS VEGAS, April 10, 2017 -- THC Therapeutics (OTC:THCT) is a publicly traded health and healing cannabis company. We are excited to announce that we have accomplished the first step of our stated plans for the growth...
OncoMed’s Phase 2 Demcizumab Pancreatic Cancer Trial Misses Primary Endpoint
Apr 10, 2017 12:03 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
Apr 10, 2017 12:03 pm UTC| Business
LAS VEGAS, April 10, 2017 -- THC Therapeutics (OTC:THCT) is a publicly traded health and healing cannabis company. We are excited to announce that we have accomplished the first step of our stated plans for the growth...
OncoMed’s Phase 2 Demcizumab Pancreatic Cancer Trial Misses Primary Endpoint
Apr 10, 2017 12:03 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
OncoMed’s Phase 2 Demcizumab Pancreatic Cancer Trial Misses Primary Endpoint
Apr 10, 2017 12:03 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
OncoMed’s Phase 2 Demcizumab Pancreatic Cancer Trial Misses Primary Endpoint
Apr 10, 2017 12:03 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...